Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Roche naming Michaela Reilly .
Filed returns
5
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| May–Aug 2026 | Roche | Health | Reframing state expenditure on innovative pharmaceuticals as a macroeconomic investment within national health and enterprise policy. (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2026 | Roche | Health | Revisions to the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) legislative frameworks in the context of Ireland’s H2 2026 Presidency of the Council of the European Union. (Legislation) | 5 | On lobbying.ie |
| May–Aug 2026 | Roche | Economic Development and Industry | Progression and refinement of legislative proposals within the EU Biotech Act during Ireland’s H2 2026 Presidency of the Council of the European Union. (Public policy or programme) | 5 | On lobbying.ie |
| May–Aug 2026 | Roche | Economic Development and Industry | Integration of established national health and clinical research implementation frameworks into Ireland’s National Life Science Strategy (Public policy or programme) | 5 | On lobbying.ie |
| May–Aug 2026 | Roche | Economic Development and Industry | Quantitative target-setting and governance structures for Ireland’s National Life Science Strategy. (Public policy or programme) | 9 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Economic Development and Industry | 3 | 60.0% | |
| Health | 2 | 40.0% |